Peter Reuter - Publications

How Much Illegally Manufactured Fentanyl Could the U.S. Be Consuming? 2022
Heroin Use Cannot Be Measured Adequately with a General Population Survey 2021
The Dawn of a New Synthetic Opioid Era: The Need for Innovative Interventions 2020
The Future of Fentanyl and Other Synthetic Opioids 2019
The Synthetic Opioid Surge in the United States: Insights from Mortality and Seizure Data 2019
Understanding America's Surge in Fentanyl and Other Synthetic Opioids 2019
Considering Heroin-Assisted Treatment and Supervised Drug Consumption Sites in the United States 2018
Exploring the Perils of Cross-national Comparisons of Drug Prevalence: The Effect of Survey Modality 2017
Beyond Prevalence: Importance of Estimating Drug Consumption and Expenditures 2015
Cocaine's Fall and Marijuana's Rise: Questions and Insights Based on New Estimates of Consumption and Expenditures in U. S. Drug Markets 2015
Considering Marijuana Legalization: Insights for Vermont and Other Jurisdictions 2015
The Marijuana Legalization Debate: Insights for Vermont 2015
Options and Issues Regarding Marijuana Legalization 2015
What Can Be Learned from Cross-National Comparisons of Data on Illegal Drugs? 2015
How Big Is the U.S. Market for Illegal Drugs? 2014
What America's Users Spend on Illegal Drugs: 2000–2010 2014
Can Tobacco Control Endgame Analysis Learn Anything from the U.S. Experience with Illegal Drugs? 2013
Managing Potential Conflict in Illegal Markets: An Exploratory Study of Cocaine Smuggling in the Netherlands 2013
Change Is Possible: The History of the International Drug Control Regime and Implications for Future Policymaking 2012
Design Considerations for Legalizing Cannabis: Lessons Inspired by Analysis of California's Proposition 19 2012
A Search-Theoretic Model of the Retail Market for Illicit Drugs 2012
The U.S. Drug Policy Landscape: Insights and Opportunities for Improving the View 2012
Addiction Research Centres and the Nurturing of Creativity: RAND's Drug Policy Research Center 2011
Basing Drug Scheduling Decisions on Scientific Ranking of Harmfulness: False Promise from False Premises 2011
Bringing Perspective to Illicit Markets: Estimating the Size of the U.S. Marijuana Market 2011
Budgeting for Immigration Enforcement: A Path to Better Performance 2011
Altered State? Assessing How Marijuana Legalization in California Could Influence Marijuana Consumption and Public Budgets 2010
How Might Marijuana Legalization in California Affect Drug Trafficking Revenues and Violence in Mexico? 2010
How Might Marijuana Legalization in California Affect Public Budgets and Marijuana Consumption? 2010
Is Medicinal Opium Production Afghanistan's Answer? A Reply to Comments 2010
Marijuana Legalization: What Can Be Learned from Other Countries? 2010
Reducing Drug Trafficking Revenues and Violence in Mexico: Would Legalizing Marijuana in California Help? 2010
Assessing Changes in Global Drug Problems, 1998-2007: Main Report 2009
Assessing the Operation of the Global Drug Market: Report 1 2009
Do Citizens Know Whether Their State Has Decriminalized Marijuana? Assessing the Perceptual Component of Deterrence Theory 2009
The Global Diversion of Pharmaceutical Drugs, India: The Third Largest Illicit Opium Producer? 2009
Is Medicinal Opium Production Afghanistan's Answer? Lessons from India and the World Market 2009
Issues in estimating the economic cost of drug abuse in consuming nations: Report 3 2009
Prime Numbers Doped: How Two Plants Wreak Havoc on the Countries That Produce and Consume Them--And Everyone in Between 2009
The unintended consequences of drug policies: Report 5 2009
Tajikistan: The Rise of a Narco-State 2007
How Much Can Treatment Reduce National Drug Problems? 2006
Welfare Receipt and Substance-Abuse Treatment Among Low-Income Mothers: The Impact of Welfare Reform 2006
What Drug Policies Cost: Estimating Government Drug Policy Expenditures 2006
Assessing U.S. Drug Problems and Policy: A Synthesis of the Evidence to Date 2005
An Assessment of ONDCP's Budget Concept 2005
How Goes the “War on Drugs”? An Assessment of U.S. Drug Problems and Policy 2005
After the Borders are Sealed: Can Domestic Sources Substitute for Imported Drugs 2004
Are the Wages of Sin $30 an Hour? Economic Aspects of Street Level Drug Dealing 2004
HAWKS Ascendant: The Punitive Trend of American Drug Policy 2004
The Limits and Consequences of U.S. Foreign Drug Control Efforts 2004
Prevalence Estimation and Policy Formulation 2004
Street Drug Markets in Inner-City Neighborhoods: Matching Policy to Reality 2004
Drug Use and Drug Policy Futures: Insights from a Colloquium 2003
Research on Drugs-Crime Linkages: The Next Generation 2003
Measuring Global Drug Markets: How Good Are the Numbers and Why Should We Care About Them? 2002
Drug War Heresies: Learning From Other Vices, Times, & Places 2001
The Limits of Supply-Side Drug Control 2001
Options for Restructuring the Safe and Drug-Free Schools and Communities Act: Report with Background Papers and Focus Group Summary 2001
Options for Restructuring the Safe and Drug-Free Schools and Communities Act 2001
Drug Use Measures: What are They Really Telling Us? 2000
Comparing the Cost-Effectiveness of Federal Mandatory Minimum Sentences and Other Federal Enforcement Programs 1999
What We Do and Don’t Know About the Likely Effects of Decriminalization and Legalization: A Brief Summary 1999
Drug Control 1998
Drug Policies and Harms: A Conceptual Framework 1998
Foreign demand for Latin American drugs : the USA and Europe 1998
Improving Block Grant Allocation Formulas: More Refined Measures Would Shift Substance Abuse Funds to Smaller, More Rural States 1998
Harm Reduction and Social Policy: Should Addicts Be Paid? 1997
Interpreting Dutch Cannabis Policy: Reasoning by Analogy in the Legalization Debate 1997
The Meaning and Utility of Drug Prices 1997
The mismeasurement of illegal drug markets : the implications of its irrelevance 1997
Review and Evaluation of the Substance Abuse and Mental Health Services Block Grant Allotment Formula 1997
Setting Goals for Drug Policy: Harm Reduction or Use Reduction? 1997
Why can't we make prohibition work better? : some consequences of ignoring the unattractive 1997
Assessing Alternative Drug Control Regimes 1996
Lessons From the Absence of Harm Reduction in American Drug Policy 1996
On the Ubiquity of Drug Selling Among Youthful Offenders in Washington, D.C., 1985-1991: Age, Period, or Cohort Effect? 1996
Prevention, The (Lauded) Orphan of Drug Policy 1995
Redefining the Goals of National Drug Policy: Recommendations from a Working Group 1995
Research on American organized crime 1995
Setting priorities : budget and program choices for drug control 1995
The cartage industry in New York 1994
Patterns of drug use 1994
A Simple Economic Model of Cocaine Production 1994
Comparing Western European and North American Drug Policies: An International Conference Report 1993
Drug Policies and Problems: The Promise and Pitfalls of Cross-National Comparison 1993
Drug Policy: Recent Lessons 1993
ONDCP’s First Four Years as a Policy Agency 1993
A Simple Economic Model of Cocaine Production 1993
Simulation of Adaptive Response: A Model of Drug Interdiction 1993
Cocaine: The First Decade 1992
Quest for Integrity: The Mexican-U.S. Drug Issue in the 1980s 1992
Improving Data for Federal Drug Policy Decisions 1991
On the Consequences of Toughness 1991
The Limits of the Czar's Ukase: Drug Policy at the Local Level 1990
Money from Crime: A Study of the Economics of Drug Dealing in Washington, D.C. 1990
Corporate Liability: How Big Is the Real Price Tag? 1989
Information Needs for Drug Abuse Policy in the Washington Metropolitan Area 1989
The Organization of High-Level Drug Markets: An Exploratory Study 1989
Quantity Illusions and Paradoxes of Drug Interdiction: Federal Intervention into Vice Policy 1989
Can the Borders Be Sealed? 1988
Drug Use and Drug Programs in the Washington Metropolitan Area 1988
The Economic Consequences of Expanded Corporate Liability: An Exploratory Study 1988
The Interdictor's Lot: A Dynamic Model of the Market for Drug Smuggling Services 1988
Measuring and Deterring Illegal Disposal of Hazardous Waste: A Preliminary Assessment 1988
Sealing the Borders: The Effects of Increased Military Participation in Drug Interdiction 1988
Simulation of Adaptive Response: A Model of Drug Interdiction 1988
Racketeering in Legitimate Industries: A Study in The Economics of Intimidation 1987
Honor Among Nations: Enforcing the ''Gentlemen's Agreement'' on Export Credits 1986
Designing Safer Products: Corporate Responses to Product Liability Law and Regulation 1985
Estimating the Shadow Economy: A Comment 1985
Eternal hope: America's international narcotics efforts 1985
Strategies for Controlling Adolescent Drug Use 1984
Cleveland Metal Stamping: Case Study of an Industry in Transition 1983
Designing Safer Products: Corporate Responses to Product Liability Law and Regulation 1983
Licensing Criminals : Police and Informants 1982
The value of a bad reputation: cartels, criminals, and barriers to entry 1982

Peter Reuter - Publications

How Much Illegally Manufactured Fentanyl Could the U.S. Be Consuming? 2022

Heroin Use Cannot Be Measured Adequately with a General Population Survey 2021

The Dawn of a New Synthetic Opioid Era: The Need for Innovative Interventions 2020

The Future of Fentanyl and Other Synthetic Opioids 2019

The Synthetic Opioid Surge in the United States: Insights from Mortality and Seizure Data 2019

Understanding America's Surge in Fentanyl and Other Synthetic Opioids 2019

Considering Heroin-Assisted Treatment and Supervised Drug Consumption Sites in the United States 2018

Exploring the Perils of Cross-national Comparisons of Drug Prevalence: The Effect of Survey Modality 2017

Beyond Prevalence: Importance of Estimating Drug Consumption and Expenditures 2015

Cocaine's Fall and Marijuana's Rise: Questions and Insights Based on New Estimates of Consumption and Expenditures in U. S. Drug Markets 2015

Considering Marijuana Legalization: Insights for Vermont and Other Jurisdictions 2015

The Marijuana Legalization Debate: Insights for Vermont 2015

Options and Issues Regarding Marijuana Legalization 2015

What Can Be Learned from Cross-National Comparisons of Data on Illegal Drugs? 2015

How Big Is the U.S. Market for Illegal Drugs? 2014

What America's Users Spend on Illegal Drugs: 2000–2010 2014

Can Tobacco Control Endgame Analysis Learn Anything from the U.S. Experience with Illegal Drugs? 2013

Managing Potential Conflict in Illegal Markets: An Exploratory Study of Cocaine Smuggling in the Netherlands 2013

Change Is Possible: The History of the International Drug Control Regime and Implications for Future Policymaking 2012

Design Considerations for Legalizing Cannabis: Lessons Inspired by Analysis of California's Proposition 19 2012

A Search-Theoretic Model of the Retail Market for Illicit Drugs 2012

The U.S. Drug Policy Landscape: Insights and Opportunities for Improving the View 2012

Addiction Research Centres and the Nurturing of Creativity: RAND's Drug Policy Research Center 2011

Basing Drug Scheduling Decisions on Scientific Ranking of Harmfulness: False Promise from False Premises 2011

Bringing Perspective to Illicit Markets: Estimating the Size of the U.S. Marijuana Market 2011

Budgeting for Immigration Enforcement: A Path to Better Performance 2011

Altered State? Assessing How Marijuana Legalization in California Could Influence Marijuana Consumption and Public Budgets 2010

How Might Marijuana Legalization in California Affect Drug Trafficking Revenues and Violence in Mexico? 2010

How Might Marijuana Legalization in California Affect Public Budgets and Marijuana Consumption? 2010

Is Medicinal Opium Production Afghanistan's Answer? A Reply to Comments 2010

Marijuana Legalization: What Can Be Learned from Other Countries? 2010

Reducing Drug Trafficking Revenues and Violence in Mexico: Would Legalizing Marijuana in California Help? 2010

Assessing Changes in Global Drug Problems, 1998-2007: Main Report 2009

Assessing the Operation of the Global Drug Market: Report 1 2009

Do Citizens Know Whether Their State Has Decriminalized Marijuana? Assessing the Perceptual Component of Deterrence Theory 2009

The Global Diversion of Pharmaceutical Drugs, India: The Third Largest Illicit Opium Producer? 2009

Is Medicinal Opium Production Afghanistan's Answer? Lessons from India and the World Market 2009

Issues in estimating the economic cost of drug abuse in consuming nations: Report 3 2009

Prime Numbers Doped: How Two Plants Wreak Havoc on the Countries That Produce and Consume Them--And Everyone in Between 2009

The unintended consequences of drug policies: Report 5 2009

Tajikistan: The Rise of a Narco-State 2007

How Much Can Treatment Reduce National Drug Problems? 2006

Welfare Receipt and Substance-Abuse Treatment Among Low-Income Mothers: The Impact of Welfare Reform 2006

What Drug Policies Cost: Estimating Government Drug Policy Expenditures 2006

Assessing U.S. Drug Problems and Policy: A Synthesis of the Evidence to Date 2005

An Assessment of ONDCP's Budget Concept 2005

How Goes the “War on Drugs”? An Assessment of U.S. Drug Problems and Policy 2005

After the Borders are Sealed: Can Domestic Sources Substitute for Imported Drugs 2004

Are the Wages of Sin $30 an Hour? Economic Aspects of Street Level Drug Dealing 2004

HAWKS Ascendant: The Punitive Trend of American Drug Policy 2004

The Limits and Consequences of U.S. Foreign Drug Control Efforts 2004

Prevalence Estimation and Policy Formulation 2004

Street Drug Markets in Inner-City Neighborhoods: Matching Policy to Reality 2004

Drug Use and Drug Policy Futures: Insights from a Colloquium 2003

Research on Drugs-Crime Linkages: The Next Generation 2003

Measuring Global Drug Markets: How Good Are the Numbers and Why Should We Care About Them? 2002

Drug War Heresies: Learning From Other Vices, Times, & Places 2001

The Limits of Supply-Side Drug Control 2001

Options for Restructuring the Safe and Drug-Free Schools and Communities Act: Report with Background Papers and Focus Group Summary 2001

Options for Restructuring the Safe and Drug-Free Schools and Communities Act 2001

Drug Use Measures: What are They Really Telling Us? 2000

Comparing the Cost-Effectiveness of Federal Mandatory Minimum Sentences and Other Federal Enforcement Programs 1999

What We Do and Don’t Know About the Likely Effects of Decriminalization and Legalization: A Brief Summary 1999

Drug Control 1998

Drug Policies and Harms: A Conceptual Framework 1998

Foreign demand for Latin American drugs : the USA and Europe 1998

Improving Block Grant Allocation Formulas: More Refined Measures Would Shift Substance Abuse Funds to Smaller, More Rural States 1998

Harm Reduction and Social Policy: Should Addicts Be Paid? 1997

Interpreting Dutch Cannabis Policy: Reasoning by Analogy in the Legalization Debate 1997

The Meaning and Utility of Drug Prices 1997

The mismeasurement of illegal drug markets : the implications of its irrelevance 1997

Review and Evaluation of the Substance Abuse and Mental Health Services Block Grant Allotment Formula 1997

Setting Goals for Drug Policy: Harm Reduction or Use Reduction? 1997

Why can't we make prohibition work better? : some consequences of ignoring the unattractive 1997

Assessing Alternative Drug Control Regimes 1996

Lessons From the Absence of Harm Reduction in American Drug Policy 1996

On the Ubiquity of Drug Selling Among Youthful Offenders in Washington, D.C., 1985-1991: Age, Period, or Cohort Effect? 1996

Prevention, The (Lauded) Orphan of Drug Policy 1995

Redefining the Goals of National Drug Policy: Recommendations from a Working Group 1995